Compare NNNN & HLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NNNN | HLX |
|---|---|---|
| Founded | 2021 | 1979 |
| Country | Germany | United States |
| Employees | 27 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | N/A | 1996 |
| Metric | NNNN | HLX |
|---|---|---|
| Price | $31.82 | $10.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $11.50 |
| AVG Volume (30 Days) | 14.1K | ★ 1.8M |
| Earning Date | 04-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $876,561,000.00 |
| Revenue This Year | N/A | $2.05 |
| Revenue Next Year | N/A | $5.46 |
| P/E Ratio | $446.57 | ★ N/A |
| Revenue Growth | N/A | ★ 3.60 |
| 52 Week Low | $7.58 | $5.52 |
| 52 Week High | $55.65 | $10.75 |
| Indicator | NNNN | HLX |
|---|---|---|
| Relative Strength Index (RSI) | 59.14 | 53.87 |
| Support Level | $26.31 | $9.22 |
| Resistance Level | $44.06 | $10.52 |
| Average True Range (ATR) | 2.86 | 0.32 |
| MACD | 0.59 | -0.02 |
| Stochastic Oscillator | 70.78 | 59.40 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. The Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S., and it also has its presence in North Sea, Brazil, Asia Pacific, West Africa, and Other.